retatrutide clinical trial south korea done! Now onto Zep! : r/Zepbound New Phase 3 retatrutide data
Description
doi:10.1016/j.maturitas.2013.04.004 Herrou J, Mabilleau G, Lecerf JM, Thomas T, Biver E, Paccou J
GLP-1 is released from intestinal L cells when nutrients are detected, when bound to its receptor, GLP-1 boosts cAMP levels, which helps trigger the release of insulin

A simple site rotation schedule eliminates this risk entirely
Enhanced Efficacy with Dual-Action Medications: Newer agents like tirzepatide, which target both GLP-1 and GIP receptors, have often demonstrated superior blood sugar lowering and more significant weight loss in clinical trials compared to GLP-1 RAs that only target one receptor

P.PoulterN

But not at the elite level, he added